vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Shake Shack Inc. (SHAK). Click either name above to swap in a different company.
Shake Shack Inc. is the larger business by last-quarter revenue ($366.7M vs $268.1M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -0.1%, a 1.4% gap on every dollar of revenue. On growth, Shake Shack Inc. posted the faster year-over-year revenue change (14.3% vs 9.7%). Over the past eight quarters, Shake Shack Inc.'s revenue compounded faster (7.6% CAGR vs 5.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Shake Shack is an American multinational fast casual restaurant chain based in New York City. It started out as a hot dog cart inside Madison Square Park in 2001, and its popularity steadily grew. In 2004, it received a permit to open a permanent kiosk within the park, expanding its menu from New York–style hot dogs to one with hamburgers, hot dogs, fries and its namesake milkshakes.
ACAD vs SHAK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $366.7M |
| Net Profit | $3.6M | $-294.0K |
| Gross Margin | — | — |
| Operating Margin | -1.7% | — |
| Net Margin | 1.4% | -0.1% |
| Revenue YoY | 9.7% | 14.3% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.02 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $366.7M | ||
| Q4 25 | $284.0M | $400.5M | ||
| Q3 25 | $278.6M | $367.4M | ||
| Q2 25 | $264.6M | $356.5M | ||
| Q1 25 | $244.3M | $320.9M | ||
| Q4 24 | $259.6M | $328.7M | ||
| Q3 24 | $250.4M | $316.9M | ||
| Q2 24 | $242.0M | $316.5M |
| Q1 26 | $3.6M | $-294.0K | ||
| Q4 25 | $273.6M | $11.8M | ||
| Q3 25 | $71.8M | $12.5M | ||
| Q2 25 | $26.7M | $17.1M | ||
| Q1 25 | $19.0M | $4.2M | ||
| Q4 24 | $143.7M | $8.7M | ||
| Q3 24 | $32.8M | $-10.2M | ||
| Q2 24 | $33.4M | $9.7M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 4.7% | ||
| Q3 25 | 12.8% | 5.0% | ||
| Q2 25 | 12.2% | 6.3% | ||
| Q1 25 | 7.9% | 0.9% | ||
| Q4 24 | 59.1% | 3.1% | ||
| Q3 24 | 12.6% | -5.7% | ||
| Q2 24 | 12.6% | 3.4% |
| Q1 26 | 1.4% | -0.1% | ||
| Q4 25 | 96.3% | 3.0% | ||
| Q3 25 | 25.8% | 3.4% | ||
| Q2 25 | 10.1% | 4.8% | ||
| Q1 25 | 7.8% | 1.3% | ||
| Q4 24 | 55.4% | 2.6% | ||
| Q3 24 | 13.1% | -3.2% | ||
| Q2 24 | 13.8% | 3.1% |
| Q1 26 | $0.02 | $-0.01 | ||
| Q4 25 | $1.61 | $0.28 | ||
| Q3 25 | $0.42 | $0.30 | ||
| Q2 25 | $0.16 | $0.41 | ||
| Q1 25 | $0.11 | $0.10 | ||
| Q4 24 | $0.86 | $0.22 | ||
| Q3 24 | $0.20 | $-0.26 | ||
| Q2 24 | $0.20 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $313.6M |
| Total DebtLower is stronger | — | $248.0M |
| Stockholders' EquityBook value | — | $554.6M |
| Total Assets | $1.6B | $1.9B |
| Debt / EquityLower = less leverage | — | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $313.6M | ||
| Q4 25 | $177.7M | $360.1M | ||
| Q3 25 | $258.0M | $357.8M | ||
| Q2 25 | $253.6M | $336.8M | ||
| Q1 25 | $217.7M | $312.9M | ||
| Q4 24 | $319.6M | $320.7M | ||
| Q3 24 | $155.1M | $310.9M | ||
| Q2 24 | $177.1M | $304.4M |
| Q1 26 | — | $248.0M | ||
| Q4 25 | — | $247.7M | ||
| Q3 25 | — | $247.5M | ||
| Q2 25 | — | $247.2M | ||
| Q1 25 | — | $246.9M | ||
| Q4 24 | — | $246.7M | ||
| Q3 24 | — | $246.4M | ||
| Q2 24 | — | $246.2M |
| Q1 26 | — | $554.6M | ||
| Q4 25 | $1.2B | $525.3M | ||
| Q3 25 | $917.3M | $509.0M | ||
| Q2 25 | $822.4M | $494.1M | ||
| Q1 25 | $765.2M | $473.3M | ||
| Q4 24 | $732.8M | $470.0M | ||
| Q3 24 | $577.2M | $456.1M | ||
| Q2 24 | $516.7M | $462.4M |
| Q1 26 | $1.6B | $1.9B | ||
| Q4 25 | $1.6B | $1.9B | ||
| Q3 25 | $1.3B | $1.8B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.1B | $1.7B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $976.9M | $1.7B | ||
| Q2 24 | $914.1M | $1.7B |
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.52× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $8.5M | ||
| Q4 25 | $-48.7M | $63.1M | ||
| Q3 25 | $74.3M | $63.0M | ||
| Q2 25 | $64.0M | $65.0M | ||
| Q1 25 | $20.3M | $31.2M | ||
| Q4 24 | $40.4M | $45.1M | ||
| Q3 24 | $63.2M | $41.9M | ||
| Q2 24 | $25.0M | $53.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $4.0M | ||
| Q3 25 | $73.9M | $23.7M | ||
| Q2 25 | — | $26.9M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $10.4M | ||
| Q3 24 | $63.2M | $7.1M | ||
| Q2 24 | — | $20.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | 26.5% | 6.5% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 25.2% | 2.2% | ||
| Q2 24 | — | 6.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 14.8% | ||
| Q3 25 | 0.1% | 10.7% | ||
| Q2 25 | — | 10.7% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | 0.0% | 11.0% | ||
| Q2 24 | — | 10.4% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 5.34× | ||
| Q3 25 | 1.03× | 5.04× | ||
| Q2 25 | 2.40× | 3.79× | ||
| Q1 25 | 1.07× | 7.36× | ||
| Q4 24 | 0.28× | 5.18× | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 5.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
